top of page

Lesson 1: Attraction Is Not Alignment

It started unexpectedly.



A brief conversation on a train. I was speaking about cancer research, about mission, about why I believed drug development needed to change. The kind of conversation you have when you forget you’re networking and simply speak from conviction.


He listened carefully. Asked questions. Requested my number.


Later, I learned he had built an extraordinary empire in a completely different industry. Established. Powerful. Used to operating at scale.


When we met again, the offer sounded simple and decisive:

“You bring the idea. I put down the money.”

For a founder in biotech, those words are disarming. Encouraging. Flattering. They make you feel chosen, not just funded.

At the time, I already had a concept drafted. A model integrating organoids, organ-on-chip systems, and AI-driven prediction. It had been evolving in my mind since 2022. So I did what any serious founder would do: I structured it. Phases. Projections. Partners. Revenue assumptions. A roadmap grounded in reality.


Our early conversations were mission-driven. Passion-led. Exploratory.


Then something subtle shifted.

The questions moved from why this matters to what are the numbers.

 From impact to ownership.

 From how we build to who controls.

There was nothing aggressive about it. No conflict. Just a different lens.


And here is the first lesson I want to share:


✔️ Not all capital understands the industry it is entering.


Biotech is not a business where control guarantees outcome. 

It is long-cycle, high-risk, governance-sensitive, reputation-dependent. Especially at the earliest stage.

Eventually, the conversation crystallized around a condition: participation required equal control. 50% vs 50%

That was the moment clarity arrived.

It wasn’t about percentage. It wasn’t ego. It wasn’t negotiation tactics.

It was about recognizing that a control-driven framework imported from another industry does not translate into early-stage biotech without distorting its structure. And that’s when I didn’t say yes.


Because here is the real lesson:

✔️ Being admired is not the same as being aligned.

✔️ Being funded is not the same as being understood.


Saying no was not a rejection of opportunity.

It was a protection of the model I was building.

And that distinction defines the rest of this journey.



Next lesson: The Difference Between Interest and Commitment



Comments


bottom of page